Kinesis Pharmaceuticals Private Limited
About Kinesis Pharmaceuticals Private Limited
Data last updated:
Kinesis Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1994PTC027081. Its GSTIN is 33AAACK2169F1ZV (Tamil Nadu).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Olaganathan Meenakshi and Arumugam Olaganathan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.87 & 96 Mohammed Hussain Colony Vivekanada Nagar Main Road Kolathur, Chennai, Tamil Nadu, India – 600099.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.04 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹28.44 Lakh (net margin 4%) and EBITDA of ₹29.28 Lakh (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 17% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.82 Cr; the latest was in March 2012. Its 4 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 1 smaller; the largest is Siyona Designers Private Limited with revenue of ₹7.05 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kinesis Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.87 & 96 Mohammed Hussain Colony Vivekanada Nagar Main Road Kolathur, Chennai, Tamil Nadu, India – 600099
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Kinesis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kinesis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kinesis Pharmaceuticals Private Limited, buy the company report.
Financials of Kinesis Pharmaceuticals Private Limited
FY 2025 filings availableKinesis Pharmaceuticals Private Limited reported revenue of ₹7.04 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 9% fall in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kinesis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kinesis Pharmaceuticals Private Limited
Kinesis Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Olaganathan Meenakshi Also directs: Cosmo Clinical Research LLP, Kinesis Laboratories Private Limited, Chennai Drugs & Pharmaceuticals Private Limited and 1 more | Director | 27 Jan 2011 | 15 Years 9 Months | Current |
| Viswanathan Shanmugasundaram Also directs: Baddi Print Packs Private Limited, Kinesis Laboratories Private Limited, Flaring Formulations Private Limited and 5 more | Additional Director | 01 Aug 2022 | 4 Years 3 Months | Current |
| Arumugam Olaganathan Also directs: Cosmo Clinical Research LLP, Zota Pharmaceuticals Private Limited | Director | 15 Mar 2010 | 16 Years 7 Months | Current |
Peer comparison
Kinesis Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siyona Designers Private Limited | ₹7.05 Cr (FY 2024) | 5.0% | Kolkata, West Bengal, India | |||
| Vivex Pharmaceuticals Private Limited | ₹7.05 Cr (FY 2024) | 51.0% | Mohali, Punjab, India | |||
| Qren Lifesciences Private Limited | ₹7.05 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Kinesis Pharmaceuticals Private Limitedthis company | ₹7.04 Cr (FY 2025) | ₹28.44 Lakh | 4% | -9.0% | 33 | Chennai, Tamil Nadu, India |
| Mentok Healthcare Private Limited | ₹6.99 Cr (FY 2022) | 54.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Kinesis Pharmaceuticals Private Limited, buy the company report.
Auditor
Kinesis Pharmaceuticals Private Limited is audited by M S PANDIAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S PANDIAN & CO | FY 2023 | 29177 |
Shareholding
The shareholding of Kinesis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kinesis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jan 1998 | 90282973 | The Vysya Bank Limited | ₹5 Lakh | Open | |
| 16 Feb 1995 | 90281903 | Indian Overseas Bank | ₹1 Lakh | Open |
To see the full charge records of Kinesis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Kinesis Pharmaceuticals Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.82 Cr; the latest was in March 2012.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jan 2011 | Funding round | ₹1.54 Cr | Investors: 2 individuals |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Funding round | ₹28 Lakh | Investors: an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Kinesis Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kinesis Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Kinesis Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed by the company against M/S Parabolic Drugs Ltd | Disposed |
To see the full case history of Kinesis Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kinesis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kinesis Pharmaceuticals Private Limited has a workforce of 33 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Kinesis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACK2169F1ZV | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kinesis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kinesis Pharmaceuticals Private Limited has 7 board changes on record since 2010: 3 appointments and 4 cessations. The latest: Arumugam Olaganathan ceased to be Managing Director on 02 Aug 2022.
1 earlier event is in the company report.
Frequently asked questions
Kinesis Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 March 1994 (32+ years old) and is registered under CIN U24231TN1994PTC027081.
Kinesis Pharmaceuticals has 3 current directors:
- Olaganathan Meenakshi - Director
- Viswanathan Shanmugasundaram - Additional Director
- Arumugam Olaganathan - Director
The latest financial statements of Kinesis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kinesis Pharmaceuticals is 33AAACK2169F1ZV, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Kinesis Pharmaceuticals is U24231TN1994PTC027081. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kinesis Pharmaceuticals has 1 court case on record: 1 filed by the company.
Kinesis Pharmaceuticals was incorporated on 22 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chennai.
Kinesis Pharmaceuticals has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.82 Cr; the latest was in March 2012.
The peers of Kinesis Pharmaceuticals by revenue are Siyona Designers Private Limited, Vivex Pharmaceuticals Private Limited, Qren Lifesciences Private Limited, Mentok Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Arumugam Olaganathan ceased to be Managing Director on 02 Aug 2022. Viswanathan Shanmugasundaram was appointed as Additional Director on 01 Aug 2022. Ananthanarayanan Varadarajan ceased to be Director on 06 Aug 2012. Kinesis Pharmaceuticals has 7 board changes on record in total.
The registered office of Kinesis Pharmaceuticals is at No.87 & 96 Mohammed Hussain Colony Vivekanada Nagar Main Road Kolathur, Chennai, Tamil Nadu, India – 600099.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
